
Sign up to save your podcasts
Or
Ari Paparo and Eric Franchi speak with Josh Walsh, founder and CEO of BranchLab, about how pharmaceutical advertising is changing. The discussion covers BranchLab’s use of neural networks with non-health data, the impact of new privacy regulations, and recent funding from Lance Armstrong’s Next Ventures. The conversation also touches on Deep Intent’s acquisition, ongoing federal policy debates, and the broader implications for healthcare marketing.
Takeaways
Chapters
00:00 – Introductions
02:00 – What BranchLab Does
05:00 – Funding from Next Ventures
07:30 – Industry Context
09:30 – Data and Privacy
13:00 – Federal Policy
16:30 – The Road Ahead
20:00 – Wrap-Up
Learn more about your ad choices. Visit megaphone.fm/adchoices
5
2020 ratings
Ari Paparo and Eric Franchi speak with Josh Walsh, founder and CEO of BranchLab, about how pharmaceutical advertising is changing. The discussion covers BranchLab’s use of neural networks with non-health data, the impact of new privacy regulations, and recent funding from Lance Armstrong’s Next Ventures. The conversation also touches on Deep Intent’s acquisition, ongoing federal policy debates, and the broader implications for healthcare marketing.
Takeaways
Chapters
00:00 – Introductions
02:00 – What BranchLab Does
05:00 – Funding from Next Ventures
07:30 – Industry Context
09:30 – Data and Privacy
13:00 – Federal Policy
16:30 – The Road Ahead
20:00 – Wrap-Up
Learn more about your ad choices. Visit megaphone.fm/adchoices
1,284 Listeners
1,084 Listeners
527 Listeners
9,550 Listeners
556 Listeners
172 Listeners
72 Listeners
43 Listeners
5,451 Listeners
265 Listeners
89 Listeners
31 Listeners
489 Listeners
10 Listeners
0 Listeners